Board of Directors
Denny Cherette Denny Cherette began his real estate career in 1977 and founded his first real estate firm in 1982. After selling that to a large development group, he founded Investment Property Associates (IPA) in 1985, where he served as president and partner for more than 26 years. In 1993, he co-founded IPA Management to oversee the company�s growing portfolio. Under his leadership, IPA and IPA Management grew to more than 130 employees with operations throughout western Michigan and Phoenix, Arizona. Primary services including developing properties for the company�s portfolio, third-party fee based development, fee-based real estate strategic planning and consulting, and full service property management for multifamily and commercial properties. In early 2012, Denny left IPA and IPA Management to establish Cherette Group. By that time, IPA�s portfolio had grown to more than 5 million square feet owned and/or managed. Denny has been involved in the leadership of many community organizations including Chairman of the Board of Global Business Leadership Center, Chairman of the Board of Mercy General Health Partners, Chairman of the Economic Development Corporation of the City of Grand Haven, MI and he is also a Founding Member, and Member of the Board of Directors for the Osteopathic Foundation of West Michigan.
Shelia Crowley, PhD., R.N. Dr. Sheila Crowley is a Registered Nurse with 35 years of cancer nursing experience with a specialization in adult Oncology practice. She began her career at the University of Chicago Hospitals and Clinics as a Nurse Clinician for the GI Oncology patient population, followed by a position as the Director of Critical Care Nursing at Greater Southeast Community Hospital in Washington, DC. Dr. Crowley continued her cancer nursing focus at the University of Michigan Health System in positions including Oncology Clinical Nurse Specialist, Director of Patient Care Services, and most recently as Director of the Adult Cancer Survivorship Program at the University of Michigan Comprehensive Cancer Center. She held an adjunct faculty position at the University of Michigan School of Nursing. After concluding her professional career, Dr. Crowley has been a community activist and volunteer. She has served on community boards in Ann Arbor including Arbor Hospice Board of Directors and the University Musical Society Advisory Committee. Dr. Crowley is an active volunteer at the Family Learning Institute and has been an active supporter of the U-M Cancer Center. She is the administrator for the Crowley Scholarship Fund at the Jackson Community Foundation. Dr. Crowley received her undergraduate degree at Nazareth College in Kalamazoo, Michigan and graduate degrees from the University of Maryland (MS) and the University of Michigan (PhD). She is married, mother of two, and grandmother of one.
Mary Kay FarleyMary Kay Farley received her degree from the Manhattanville College in New York and obtained a Master of Social Work from Loyola University in Chicago. She became a board member and executive vice-president of the Orthopaedic Research and Education Foundation. She organized a National Board of orthopaedic fundraisers in her 6 years of service at the OREF. Ms. Farley has served as a trustee of Manhattan College and International House, both in New York City. She was a trustee of Barry University in Mariam, Florida and a trustee of Northern Michigan Hospital in Petoskey, Michigan and St. Mary's Hospital in Palm Beach, Florida. She was also a director of the Los Angeles Orthopaedic Hospital and Foundation while living in California. She is a member of the RAND Corporation's Board of Health Advisors and she travels to California to discuss health policy issues. She is a wife, mother of 4, grandmother of 6 and leads a busy and active life.
Jeffrey Gaier is Managing Partner of the Wealth Planning Resources Group, LLC, a national private wealth practice based in Florham Park, New Jersey. As an attorney and Certified Financial Planner, also Certified in Long-Term Care, Mr. Gaier has specialized since 1983 in the financial services profession, primarily in the areas of estate and philanthropic planning, while also counseling individuals and business entities on retirement plan design and executive compensation. Mr. Gaier is admitted to practice law in New York and New Jersey, as well as the United States Tax Court. He also holds Series 7 & 63 investment licenses, along with certifications in life, disability, and long-term care insurance. Previously, Mr. Gaier served as Trust and Estate Manager and Senior Vice President with Merrill Lynch Trust Company, based at the firm's world headquarters in New York. Prior to joining Merrill Lynch, Mr. Gaier headed the Wealth Planning Strategies Group for Bankers Trust Private Banking, also in New York. Earlier in his career, Mr. Gaier was trained as a tax attorney with the Personal Financial Services (PFS) Group at Coopers & Lybrand, LLP (now PricewaterhouseCoopers). Mr. Gaier also served as law clerk to the Honorable Joseph C. Small of the Tax Court of New Jersey. Mr. Gaier lives in Livingston, New Jersey with his wife Sherry, and two daughters, Jillian and Dana. Jeffrey Gaier, Esq.
Bruce Gershenson, Founder of Gershenson Realty and Investment, is a recognized expert in commercial retail development. Mr. Gershenson began his career working with his father, uncle and brothers developing shopping centers. In 1972 he became a principal in Ramco-Gershenson, Inc., and was directly responsible for identifying development opportunities, land acquisition, and brokerage for the Company. In 1996, Mr. Gershenson became Executive Vice President and Treasurer of Ramco-Gershenson Properties Trust, a newly formed Real Estate Investment Trust traded on the New York Stock Exchange. He also became President of Ramco-Gershenson, Inc., the management subsidiary of Ramco-Gershenson Properties Trust. His chief role with the company was head of the Acquisition Department, which was responsible for acquiring 24 centers in three years. Mr. Gershenson founded Gershenson Realty and Investment in 2001 and brings to the Company his many years of experience and knowledge. He has an undergraduate degree from the University of Michigan, as well as a Juris Doctorate degree from Wayne State University. Bruce Gershenson
Richard H. Rogel of Avon, Colorado, is the former Chairman and Chief Executive Officer of the Preferred Provider Organization of Michigan. Born in Essex, New Jersey, Mr. Rogel earned a bachelor in business administration degree from the University of Michigan. He was Valedictorian of the 1970 Business School class, and he is a former president of the University of Michigan's Alumni Association. At the University of Michigan, Mr. Rogel currently serves on the Health System's Advisory Group, and its Pancreatic Board of Directors. During our last university campaign, The Michigan Difference, Mr. Rogel served as Chair. Mr. Rogel is also a member of President Mary Sue Colemans Advisory Group, the University Musical Society Senate, the Social Work Development Committee Campaign Taskforce, the Advisory Board of the Samuel Zell and Robert H. Lurie Institute for Entrepreneurial Studies, the Greater Detroit Leadership Gift Committee, the Directors Cabinet in the Department of Intercollegiate Athletics, the Health System Task Force, and the Board of Directors of the Alumni Association. Mr. Rogel is a member of the American Association of Preferred Provider Organization, the American Preferred Health Networks, the American Hospital Association, and the Greater Detroit Health Council. He is non-operating chairman of CoolSavings.com and Director of Quelsys, Incorporated. Mr. Rogel serves as a director of the Michigan Cancer Foundation. Richard Rogel
Dr. Diane Simeone is the Lazar J. Greenfield Professor of Surgery, of Physiology, and Division Chief of HPB and Advanced GI Surgery at the University of Michigan Medical Center. She is the Director of the GI Oncology Program for the University of Michigan Comprehensive Cancer Center and the co-PI of the University of Michigan SPORE Grant in GI Malignancies. Dr. Simeones principal clinical interests are in the management of solid and cystic pancreatic tumors. She is the Director of the University of Michigan Pancreatic Cancer Center and of the Translational Oncology Program. Dr. Simeone has multiple NIH grants investigating the molecular mechanisms important in the development and progression of pancreatic adenocarcinoma and the function of cancer stem cells. She also leads several studies developing biomarkers for the early diagnosis of pancreatic malignancy. She currently serves as an Associate Editor of the journal Gastroenterology and is the past-President of the Society of University Surgeons and the American Pancreatic Association. Dr. Simeone serves on the Scientific Advisory Board for the Pancreatic Cancer Action Network, National Pancreas Foundation, and the NCI Pancreatic Cancer Task Force. Dr. Simeone is a member of the Institute of Medicine. Diane Simeone, M.D.
Marvin B. Tepper is a Partner at Sterling Equities. He has over 30 years of experience in legal, finance, tax, and investment matters. Prior to Sterling, Mr. Tepper was a Senior Partner in a New York law firm where he built an extensive practice in real estate, corporate, and commercial matters. He served as Secretary of PathoGenesis Corporation. Mr. Tepper is the Chairman of the Board of Zoning and Appeals of the Village of Sands Point, NY and participates in various other civic and philanthropic organizations. He is a Member of the Investment Committee at Sterling American Property Inc. Mr. Tepper received a law degree from NYUs School of Law and an A.B. degree from New York University. Marvin B. Tepper
Max Wicha is the founding and current director of the University of Michigan Comprehensive Cancer Center and the Distinguished Professor of Oncology. Under his direction, the Cancer Center has established itself as a national leader. It currently receives more funding from the National Cancer Institute than any other university-based center. Dr. Wicha is also a leader in breast cancer research and has been a pioneer in the field of cancer stem cells. According to the science citation index, he is the most highly cited investigator in this field. Dr. Wichas group was part of the team that first identified cancer stem cells in human breast cancers, the first in any solid tumor. His laboratory has developed most of the techniques and assays used to study these cells and to elucidate the pathways which regulate their behavior. These pathways have provided targets for the development of drugs aimed at targeting cancer stem cells. The UMCCC has established itself as a world leader in cancer stem cell biology and therapeutics and is currently conducting nine early phase clinical trials aimed at targeting cancer stem cells, the most of any center in the world. Dr. Wicha is co- founder of OncoMed Pharmaceuticals, a biotech technology company focused on developing cancer stem cell therapeutics, which has produced three agents currently in clinical testing. Dr. Wicha is also a practicing clinician whose practice is focused on women with breast cancer. He also serves on advisory boards of eight NCI cancer centers and several biotechnology companies. Max Wicha, M.D.